Preliminary results of a randomised phase III trial of an established chemotherapy (CT) regimen with or without lenograstim (rHuG-CSF) in small cell lung cancer (SCLC): Impact on survival

✍ Scribed by Gatzemeier, U.; Thomas, P.; Cardenal, F.; Snijder, R.J.; Samaras, N.; Melo, M.J.; Aumann, J.; Hermann, R.; Puganigg, K.; Badri, N.

• Book ID: 121912947
• Publisher: Elsevier Science
• Year: 1997
• Tongue: English
• Weight: 215 KB
• Volume: 33
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/S0959-8049(97)85808-X